Insider Transactions in Q2 2022 at Biogen Inc. (BIIB)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 15
2022
|
Alexander J Denner Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,370
+8.32%
|
-
|
|
Jun 15
2022
|
Caroline Dorsa Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,370
+5.57%
|
-
|
|
Jun 15
2022
|
Maria C Freire Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,370
+38.98%
|
-
|
|
Jun 15
2022
|
William A Hawkins Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,370
+24.64%
|
-
|
|
Jun 15
2022
|
William D /Ca/ Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,370
+38.98%
|
-
|
|
Jun 15
2022
|
Jesus B Mantas Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,370
+21.21%
|
-
|
|
Jun 15
2022
|
Richard Mulligan Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,370
+8.32%
|
-
|
|
Jun 15
2022
|
Stelios Papadopoulos Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,255
+18.26%
|
-
|
|
Jun 15
2022
|
Eric K Rowinsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,370
+6.66%
|
-
|
|
Jun 15
2022
|
Stephen A Sherwin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,370
+6.9%
|
-
|
|
Apr 01
2022
|
Nicole Murphy Head of Pharm Ops and Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
84
-4.43%
|
$17,640
$210.65 P/Share
|
|
Apr 01
2022
|
Nicole Murphy Head of Pharm Ops and Tech |
BUY
Exercise of conversion of derivative security
|
Direct |
239
+11.19%
|
-
|